2月3日 - ** 制药商 Scienture Holdings SCNX.O 股价盘前上涨 10.34% 至 0.4993 美元
** 该公司称已扩大了Arbli的供应范围，Arbli是其治疗高血压的即用型液体洛沙坦。
** 洛沙坦治疗高血压，持续高血压会增加中风和心脏病的风险 - SCNX
** 公司称，Arbli 目前在 2,500 多个医疗保健机构有售，覆盖 1 亿投保的美国人
** 预计第一季度 Arbli 的处方量将继续增长，保险和药房覆盖范围也将扩大
** 称其用于阿片类药物过量急救的鼻腔喷雾剂 Rezenopy 将于 2026 年第二季度在美国上市
** 2025 年股价下跌约 92%
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.